{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:26:03Z","timestamp":1792099563126,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10384-020-00785-6","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T01:02:32Z","timestamp":1605142952000},"page":"63-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Twenty-four-month results of intravitreal aflibercept for macular edema due to branch retinal vein occlusion"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-0165","authenticated-orcid":false,"given":"Yoshihito","family":"Sakanishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syu","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Mashimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"785_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/archopht.126.4.513","volume":"126","author":"R Klein","year":"2008","unstructured":"Klein R, Moss SE, Meuer SM, Klein BE. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol. 2008;126:513-8.","journal-title":"Arch Ophthalmol."},{"key":"785_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1001\/archopht.124.5.726","volume":"124","author":"S Cugati","year":"2006","unstructured":"Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol. 2006;124:726-32.","journal-title":"Arch Ophthalmol."},{"key":"785_CR3","doi-asserted-by":"crossref","unstructured":"Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol. 1984;98:271-82.","DOI":"10.1016\/0002-9394(84)90316-7"},{"key":"785_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3928\/1542-8877-20050701-15","volume":"36","author":"PJ Rosenfeld","year":"2005","unstructured":"Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2005;36:336-9.","journal-title":"Ophthalmic Surg Lasers Imaging."},{"key":"785_CR5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ajo.2006.12.037","volume":"143","author":"SA Pai","year":"2007","unstructured":"Pai\u00a0SA,\u00a0Shetty R,\u00a0Vijayan PB,\u00a0Venkatasubramaniam G,\u00a0Yadav NK,\u00a0Shetty B K, et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol. 2007;143:601-6.","journal-title":"Am J Ophthalmol."},{"key":"785_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ophtha.2011.12.005","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier\u00a0JS, Campochiaro PA,\u00a0Yau L,\u00a0Li Z,\u00a0Saroj N,\u00a0Rubio RJ, et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology. 2012;119:802-9.","journal-title":"Ophthalmology."},{"key":"785_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ophtha.2015.09.035","volume":"123","author":"WL Clark","year":"2016","unstructured":"Clark WL, Boyer DS, Heier JS, Brown DM, Haller JA, Vitti R, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the VIBRANT study. Ophthalmology. 2016;123:330-6.","journal-title":"Ophthalmology."},{"key":"785_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2019.1681474","volume":"13","author":"B K\u00fc\u00e7\u00fck","year":"2019","unstructured":"K\u00fc\u00e7\u00fck B, Sirakaya E, Karaca C. Comparison of ranibizumab versus aflibercept in treating macular edema among patients with serous retinal detachment secondary to branch retinal vein occlusion Ocul Immunol Inflamm. 2019;13:1-8.","journal-title":"Ocul Immunol Inflamm."},{"key":"785_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10792-017-0798-6","volume":"39","author":"F Pichi","year":"2019","unstructured":"Pichi F, Elbarky AM, Elhamaky TR. Outcome of \u201ctreat and monitor\u201d regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion. Int Ophthalmol. 2019;39:145-53.","journal-title":"Int Ophthalmol."},{"key":"785_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/IAE.0000000000001579","volume":"38","author":"I Chatziralli","year":"2018","unstructured":"Chatziralli I, Theodossiadis G, Chatzirallis A, Parikakis E, Mitropoulos P, Theodossiadis P. RANIBIZUMAB FOR RETINAL VEIN OCCLUSION: predictive factors and long-term outcomes in real-life data. Retina. 2018;38:559-68.","journal-title":"Retina."},{"key":"785_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/aos.12772","volume":"93","author":"S Rezar","year":"2015","unstructured":"Rezar S,\u00a0Eibenberger K,\u00a0B\u00fchl W,\u00a0Georgopoulos M, Schmidt-Erfurth\u00a0M, et al. Anti-VEGF treatment in branch retinal vein occlusion: a real-world experience over 4\u00a0years. Acta Ophthalmol. 2015;93:719-25.","journal-title":"Acta Ophthalmol."},{"key":"785_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000487489","volume":"60","author":"MM Guichard","year":"2018","unstructured":"Guichard MM, Xavier AR, T\u00fcrksever C, Pruente C, Hatz K. Spectral-domain optical coherence tomography-driven treat-and-extend and pro re nata regimen in patients with macular oedema due to retinal vein occlusion: 24 month evaluation and outcome predictors. Ophthalmic Res. 2018;60:29-37.","journal-title":"Ophthalmic Res."},{"key":"785_CR13","doi-asserted-by":"crossref","unstructured":"Yasuda M,\u00a0Kiyohara Y,\u00a0Arakawa S,\u00a0Hata Y,\u00a0Yonemoto K,\u00a0Doi Y, et al. Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci. 2010;51:3205-9.","DOI":"10.1167\/iovs.09-4453"},{"key":"785_CR14","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1016\/j.ophtha.2014.06.011","volume":"121","author":"PA Campochiaro","year":"2014","unstructured":"Campochiaro PA,\u00a0Wykoff\u00a0CC,\u00a0Singer M,\u00a0Johnson R,\u00a0Marcus D,\u00a0Yau L, et al. Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study. Ophthalmology. 2014;121:2432-42.","journal-title":"Ophthalmology."},{"key":"785_CR15","doi-asserted-by":"crossref","unstructured":"Singer M, Tan CS, Bell D,\u00a0SAdda SR. Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion. Retina. 2014 Sep;34:1736-42.","DOI":"10.1097\/IAE.0000000000000148"},{"key":"785_CR16","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1097\/IAE.0b013e3182794b06","volume":"33","author":"G Mylonas","year":"2013","unstructured":"Mylonas G,\u00a0Sacu S,\u00a0Dunavoelgyi R,\u00a0Matt G,\u00a0Blum R,\u00a0Buehl W, et al. Response of retinal sensitivity to ranibizumab treatment of macular edema after acute branch retinal vein occlusion. Retina. 2013;33:1220-6.","journal-title":"Retina."},{"key":"785_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ophtha.2013.08.038","volume":"121","author":"PA Campochiaro","year":"2014","unstructured":"Campochiaro PA,\u00a0Sophie R,\u00a0Pearlman J,\u00a0Brown DM, Boyer DS,\u00a0Heier JS, et al. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology. 2014;121:209-19.","journal-title":"Ophthalmology."},{"key":"785_CR18","doi-asserted-by":"publisher","first-page":"29445","DOI":"10.1038\/srep29445","volume":"6","author":"T Tomiyasu","year":"2016","unstructured":"Tomiyasu T,\u00a0Yoshio Hirano Y,\u00a0Yoshida\u00a0M,\u00a0Suzuki\u00a0N,\u00a0Nishiyama T,\u00a0Uemura\u00a0A, et al. Microaneurysms cause refractory macular edema in branch retinal vein occlusion. Sci Rep. 2016;6:29445.","journal-title":"Sci Rep."},{"key":"785_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s10384-016-0425-5","volume":"60","author":"Y Iesato","year":"2016","unstructured":"Iesato Y, Imai A, Hirano T, Toriyama Y, Murata T. Effect of leaking capillaries and microaneurysms in the perifoveal capillary network on resolution of macular edema by anti-vascular endothelial growth factor treatment. Jpn J Ophthalmol. 2016;60:86-94.","journal-title":"Jpn J Ophthalmol."},{"key":"785_CR20","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/S0161-6420(96)30420-X","volume":"103","author":"MJ Tolentino","year":"1996","unstructured":"Tolentino\u00a0M J, Miller JW,\u00a0Gragoudas ES,\u00a0Jakobiec FA,\u00a0Flynn E,\u00a0Chatzistefanou K, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology. 1996;103:1820-8.","journal-title":"Ophthalmology."},{"issue":"1094\u20131101","key":"785_CR21","first-page":"e5","volume":"117","author":"SL Rogers","year":"2010","unstructured":"Rogers\u00a0SL,\u00a0McIntosh RL,\u00a0Lim L,\u00a0Mitchell P,\u00a0Cheung N,\u00a0Kowalski JW, et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117:1094\u20101101.e5.","journal-title":"Ophthalmology."}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-020-00785-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-020-00785-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-020-00785-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T18:05:37Z","timestamp":1612029937000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-020-00785-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["785"],"URL":"https:\/\/doi.org\/10.1007\/s10384-020-00785-6","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y. Sakanishi, None; K. Yasuda, None; S. Morita, None; K. Mashimo, None; K. Tamaki, None; T. Sakuma, None; N. Ebihara, None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}